BACKGROUND & AIMS: Liver fibrosis, driven by chronic injury, hinges on hepatic stellate cells (HSCs) activation. Microfibrillar-associated protein 4 (MFAP4), an extracellular matrix protein critical for elastic fiber assembly, is up-regulated in hepatic fibrosis, yet its mechanistic role remains unclear. METHODS: Liver fibrosis was induced in wild-type and Mfpa4 knockout mice using CCl(4) and TAA, whereas LX-2 cells were activated with transforming growth factor-β1. Bioinformatics analysis, histopathology, double immunofluorescence, flow cytometry, Transwell coculture systems, Western blot, and quantitative polymerase chain reaction were used to identify the primary intrahepatic cell types expressing MFAP4 and assess its effects on HSCs activation and apoptosis. RESULTS: MFAP4 is up-regulated in cirrhotic livers and is actively expressed in HSCs. Single-cell RNA sequencing analysis and Transwell coculture experiments revealed that the profibrotic effects of MFAP4 were primarily mediated through HSCs rather than hepatocytes. Inhibition of MFAP4 significantly reduces the expression of fibrosis markers in HSCs, inhibits their proliferation and migration, whereas overexpression of MFAP4 results in the opposite effect, accompanied by enhanced apoptosis resistance. In mouse models, global knockout of Mfap4 significantly alleviates CCl(4)- and TAA-induced liver fibrosis. Mechanistic analysis reveals that MFAP4 binds to integrin αvβ3 on the HSCs membrane, activating the FAK/PI3K/NFκB signaling pathway, which promotes HSC activation and survival, ultimately exacerbating liver fibrosis. Moreover, MFAP4 mediates a self-sustaining feedback loop via integrin αvβ3, maintaining HSCs activation and further promoting fibrosis progression. CONCLUSIONS: MFAP4 governs HSCs activation and apoptosis resistance via integrin αvβ3-dependent FAK/PI3K/NFκB signaling. Targeting MFAP4 mitigates fibrosis by altering HSCs fate.
MFAP4 Deficiency Attenuates Liver Fibrosis by Regulating Hepatic Stellate Cell Fate Through Inhibition of the FAK/PI3K/NFκB Signaling Pathway.
MFAP4 缺乏通过抑制 FAK/PI3K/NFαB 信号通路调节肝星状细胞命运来减轻肝纤维化
阅读:5
作者:Liu Linxiang, Li Bimin, Zhang Yue, Nie Yuan, Zhang Wang, Chen Peng, Huang Chenkai, Zhu Xuan
| 期刊: | Cellular and Molecular Gastroenterology and Hepatology | 影响因子: | 7.400 |
| 时间: | 2025 | 起止号: | 2025 May 29; 19(10):101548 |
| doi: | 10.1016/j.jcmgh.2025.101548 | 靶点: | FAK |
| 研究方向: | 信号转导、细胞生物学 | 信号通路: | PI3K/Akt |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
